Have a personal or library account? Click to login
Demographic and Clinical Characteristics of Females with Breast Cancer in Iraq with Respect to Age: A Single-Center Study Cover

Demographic and Clinical Characteristics of Females with Breast Cancer in Iraq with Respect to Age: A Single-Center Study

Open Access
|May 2024

Figures & Tables

Demographic characteristics and clinical history of the study sample_

TotalAge <50 years (n = 188)Age ≥50 years (n = 312)p-Value
Weightkg83.33 ± 9.9183.45 ± 11.0183.26 ± 9.190.84
Marital statusSingle38 (7.6%)13 (6.9%)25 (8.0%)<0.0001
Married402 (80.4%)169 (89.9%)233 (74.7%)
Widowed/divorced60 (12.0%)6 (3.2%)54 (17.3%)
Number of children053 (10.6%)18 (9.6%)35 (11.2%)<0.0001
1–2153 (30.6%)85 (45.2%)68 (21.8%)
3–5250 (50.0%)77 (41.0%)173 (55.4%)
≥644 (8.8%)8 (8.4%)36 (11.5%)
ResidenceBaghdad405 (81.0%)146 (77.7%)259 (83.0%)0.16
Other95 (19.0%)42 (22.3%)53 (17.0%)
Illiterate167 (33.4%)40 (21.3%)127 (40.7%)
Education levelPrimary school180 (36.0%)78 (41.5%)102 (32.7%)<0.0001
High school96 (19.2%)39 (20.7%)57 (18.3%)
University or higher57 (11.4%)31 (16.5%)26 (8.3%)
EmploymentUnemployed298 (59.6%)75 (39.9%)223 (71.5%)<0.0001
Employed202 (40.4%)113 (60.1%)89 (28.5%)
Socioeconomic statusLow58 (11.6%)19 (10.1%)39 (12.5%)0.38
Middle240 (48.0%)86 (45.7%)154 (49.4%)
High202 (40.4%)83 (44.1%)119 (38.1%)
Smoking 42 (8.4%)16 (8.5%)26 (8.3%)0.95
Coffee drinkingNo457 (91.4%)166 (88.3%)291 (93.3%)0.06
1–2 times per day43 (8.6%)22 (11.7%)21 (6.7%)
Physical activityNo472 (94.4%)173 (92.0%)299 (95.8%)0.07
1–2 times per week28 (5.6%)15 (8.0%)13 (4.2%)
Age at menarcheYears12.44 ± 1.3912.73 ± 1.3612.27 ± 1.390.83
<20 years69 (15.5%)15 (8.9%)54 (19.5%)
Age when first child20–29348 (78.0%)139 (82.2%)209 (75.5%)0.001
30–3520 (4.5%)13 (7.7%)7 (2.5%)
≥359 (2.0%)2 (1.2%)7 (2.5%)
History of breastfeeding 443 (99.3%)167 (98.8%)276 (99.6%)0.56
Breastfeeding duration1–3 months161 (36.1%)82 (48.5%)79 (28.5%)<0.0001
4–6 months167 (37.4%)57 (33.7%)110 (39.7%)
7–9 months110 (24.7%)25 (14.8%)85 (30.7%)
10–12 months5 (1.1%)3 (1.8%)2 (0.7%)
Abortion 104 (20.8%)31 (16.5%)73 (23.4%)0.07
Past medical historyDiabetes mellitus106 (21.2%)13 (6.9%)93 (29.8%)<0.0001
Hypertension236 (47.2%)36 (19.1%)200 (64.1%)<0.0001
Hypercholesterolemia37 (7.4%)1 (0.5%)36 (11.5%)<0.0001
Thyroid disease14 (3.2%)4 (2.4%)10 (3.8%)0.42
Heart disease26 (6.0%)0 (0.0%)26 (9.8%)<0.0001
Renal disease5 (1.0%)0 (0.0%)5 (1.6%)0.16
Vitamin D deficiency137 (27.4%)41 (21.8%)96 (30.8%)0.03
Anemia38 (7.6%)9 (4.8%)29 (9.3%)0.07
Benign breast disease11 (3.3%)3 (2.4%)8 (3.9%)0.54
Past surgical historyYes5 (1.0%)1 (0.5%)4 (1.3%)0.002
C-section56 (11.2%)33 (17.6%)23 (7.4%)
Menopause 279 (55.8%)6 (3.2%)273 (87.5%)<0.0001
Menopause ageYears49.69 ± 3.8545.50 ± 2.6549.75 ± 3.830.03
263 (52.6%)93 (49.5%)170 (54.5%)0.28
Family history of breast cancerFirst-degree relatives151 (57.4%)62 (66.7%)89 (52.4%)0.03
Second-degree relatives156 (59.3%)53 (57.0%)103 (60.6%)0.57
Family history of any cancer 51 (10.2%)21 (11.2%)30 (9.6%)0.58

Patients’ treatment and outcome_

TotalAge <50 years (n = 188)Age ≥50 years (n = 312)p-Value
Hormone therapy331 (66.2%)123 (65.4%)208 (66.7%)0.78
Radiotherapy411 (82.2%)155 (82.4%)256 (82.1%)0.91
Metastasis149 (29.8%)43 (22.9%)106 (34.0%)0.009
Recurrence52 (10.4%)17 (9.0%)35 (11.2%)0.44
Mortality98 (19.6%)24 (12.8%)74 (23.7%)0.003

Clinical presentation of the examined study sample_

TotalAge <50 years (n = 188)Age ≥50 years (n = 312)p-Value
Tumor stage04 (0.8%)1 (0.5%)3 (1.0%)0.26
172 (14.4%)25 (13.3%)47 (15.1%)
2339 (67.8%)122 (64.9%)217 (69.6%)
373 (14.6%)36 (19.1%)37 (11.9%)
412 (2.4%)4 (2.1%)8 (2.6%)
Tumor grade112 (2.4%)1 (0.5%)11 (3.5%)0.04
2268 (53.7%)110 (58.5%)158 (50.8%)
3219 (43.9%)77 (41.0%)142 (45.7%)
Tumor size 3.18 ± 1.503.30 ± 1.733.09 ± 1.340.26
Tumor sideRight169 (33.8%)60 (31.9%)109 (34.9%)0.54
Left326 (65.2%)127 (67.6%)199 (63.8%)
Bilateral5 (1.0%)1 (0.5%)4 (1.3%)
Lymph nodeN0259 (51.8%)109 (58.0%)150 (48.1%)0.08
N1208 (41.6%)65 (34.6%)143 (45.8%)
N221 (4.2%)10 (5.3%)11 (3.5%)
N312 (2.4%)4 (2.1%)8 (2.6%)
Palpable lump 410 (82.0%)153 (81.4%)257 (82.4%)0.78
Bloody nipple discharge 55 (11.0%)15 (8.0%)40 (12.8%)0.09
Ulceration change 11 (2.2%)1 (0.5%)10 (3.2%)0.06
500 (100.0%)188 (100.0%)312 (100.0%)-
Breast surgeryPartial mastectomy424 (84.8%)155 (82.4%)269 (86.2%)0.26
Total mastectomy99 (19.8%)44 (23.4%)55 (17.6%)0.12
Ductal carcinoma463 (92.6%)177 (94.1%)286 (91.7%)
Lobular carcinoma33 (6.6%)8 (4.3%)25 (8.0%)
Histopathologic subtypeTubular1 (0.2%)1 (0.5%)0 (0.0%)0.09
Mucinous (colloid)1 (0.2%)0 (0.0%)1 (0.3%)
Other rare type2 (0.4%)2 (1.1%)0 (0.0%)
DOI: https://doi.org/10.2478/fco-2023-0018 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 35 - 44
Submitted on: Oct 4, 2023
Accepted on: Dec 19, 2023
Published on: May 20, 2024
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2024 Tahseen Alrubai, Rasha Zaki, Arwa Mohsun, Ali Mohammed, Loubna Sinno, Nabih Lawand, Samaa AL Tabbah, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.